Short Interest in Aemetis, Inc. (NASDAQ:AMTX) Declines By 17.9%

Aemetis, Inc. (NASDAQ:AMTX) saw a significant decline in short interest in November. As of November 15th, there was short interest totalling 5,540,000 shares, a decline of 17.9% from the October 31st total of 6,750,000 shares. Based on an average trading volume of 670,300 shares, the short-interest ratio is presently 8.3 days.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on AMTX shares. UBS Group cut their target price on Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a report on Monday, August 19th. Ascendiant Capital Markets cut their price objective on Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Tuesday, September 3rd. Finally, HC Wainwright reaffirmed a “buy” rating and set a $28.00 target price on shares of Aemetis in a research report on Friday, November 15th. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, Aemetis currently has a consensus rating of “Moderate Buy” and a consensus target price of $12.95.

Aemetis Stock Up 1.0 %

Shares of AMTX stock opened at $4.13 on Monday. The firm has a market cap of $205.43 million, a PE ratio of -1.81 and a beta of 1.23. Aemetis has a 12 month low of $2.10 and a 12 month high of $7.03. The stock has a 50 day moving average of $3.12 and a 200-day moving average of $3.04.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.09. The firm had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same quarter in the prior year, the firm posted ($0.59) EPS. As a group, equities analysts predict that Aemetis will post -2.02 EPS for the current fiscal year.

Institutional Trading of Aemetis

Several hedge funds have recently modified their holdings of AMTX. Geode Capital Management LLC grew its position in Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after acquiring an additional 66,031 shares during the last quarter. State Street Corp lifted its position in shares of Aemetis by 36.1% during the third quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after purchasing an additional 185,304 shares in the last quarter. Susquehanna Fundamental Investments LLC grew its stake in shares of Aemetis by 287.4% during the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Aemetis in the second quarter valued at approximately $306,000. Finally, Wellington Management Group LLP bought a new position in Aemetis in the 3rd quarter worth approximately $177,000. Institutional investors and hedge funds own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.